Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes
- 30 March 1984
- journal article
- clinical trial
- Published by Elsevier in American Journal Of Medicine
- Vol. 76 (3), 83-90
- https://doi.org/10.1016/0002-9343(84)90325-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Thymosin α1Levels and Helper:Suppressor Ratios in Homosexual MenNew England Journal of Medicine, 1983
- Acquired Immune Deficiency in HaitiansNew England Journal of Medicine, 1983
- Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: Inadequacy of current dosage practices and approaches to the problemJournal of Clinical Immunology, 1982
- Individual patient variations in the kinetics of intravenous immune globulin administrationJournal of Clinical Immunology, 1982
- Modified immune globulin: Its use in the prophylactic treatment of patients with immune deficiencyJournal of Clinical Immunology, 1982
- Use of intravenous γ-globulin in antibody immunodeficiency: Results of a multicenter controlled trialClinical Immunology and Immunopathology, 1982
- Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex LesionsNew England Journal of Medicine, 1981